Overview

  • Product nameFlufenamic acid
  • Description
    NSAID. COX inhibitor, channel blocker.
  • Biological descriptionNon-steroidal anti-inflammatory. Potently inhibits human transthyretin amyloid fibril formation. Alters ion fluxes through the plasma membrane. Potent non-specific blocker of cation and anion channels, commonly used to block currents through TRP channels and receptor-operated channels.
  • Purity> 98%

Properties

    Applications

    Our Abpromise guarantee covers the use of ab120354 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Abreviews Notes
    Functional Studies Use at an assay dependent concentration.

    Flufenamic acid images

    • ab51110 staining AMPKα 1 + AMPKα 2 (phosphoT172) in HeLa cells treated with flufenamic acid (ab120354), by ICC/IF. Increase in AMPKα 1 + AMPKα 2 (phosphoT172) nuclear expression correlates with increased concentration of flufenamic acid, as described in literature.
      The cells were incubated at 37°C for 30 minutes in media containing different concentrations of ab120354 (flufenamic acid) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab51110 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.

    References for Flufenamic acid (ab120354)

    This product has been referenced in:
    • Hotta A  et al. The effects of flufenamic acid on spontaneous activity of smooth muscle tissue isolated from the guinea-pig stomach antrum. J Smooth Muscle Res 41:207-20 (2005). Read more (PubMed: 16258234) »
    • Peterson SA  et al. Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proc Natl Acad Sci U S A 95:12956-60 (1998). Read more (PubMed: 9789022) »
    • Flower RJ Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26:33-67 (1974). Read more (PubMed: 4208101) »
    • Tu P  et al. The anti-inflammatory agent flufenamic acid depresses store-operated channels by altering mitochondrial calcium homeostasis. Neuropharmacology 56:1010-6 (0). Read more (PubMed: 19233217) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120354.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"